Target intelligence / Profile preview

Double homeobox 4 like 20 (DUX4L20)

Target
DUX4L20
Molecular classification
Other (pseudogene)
01

Overview

Double homeobox 4 like 20 (DUX4L20) is classified as a pseudogene in humans, meaning it arises from a duplication of a related gene (DUX4) but does not encode a functional protein product[4]. DUX4L20 has sequence similarity to DUX4, a transcription factor involved in embryonic development and also implicated in facioscapulohumeral muscular dystrophy (FSHD)[1][5], but DUX4L20 itself is not known to have any biological function, interact with drugs, or serve as a therapeutic target. There is no evidence that DUX4L20 plays a role in physiological or disease processes nor that it encodes a functional protein[4]. Its presence is sometimes mentioned in genetic studies due to shared ancestry with DUX4. Clarification: The protein-coding DUX4 gene/protein (not DUX4L20) is a recognized transcription factor and is being studied as a therapeutic target, particularly in cancer and muscular dystrophy[1][2][3][5]. If your interest is in the biologically active molecule, you should refer to Double homeobox 4 (DUX4), not "Double homeobox 4 like 20" (DUX4L20). DUX4L20 is a non-functional pseudogene and not relevant as a therapeutic or biological target[4].

Other names
DUX4L20Double homeobox 4-like 20
02

Biological functions

Other (no established function; pseudogene)
03

Disease associations

Muscular dystrophy (association noted through homology/paralogy, not direct causation)[4]

Beyond the preview

Go deeper on Double homeobox 4 like 20 (DUX4L20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double homeobox 4 like 20 (DUX4L20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call